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Discovery of catalytic antibodies (abzymes) was a revolutionary event that created new junctions
between chemistry, biochemistry, immunology and pathology. Creation of abzymes is based on the
intrinsic properties of immunoglobulin superfamily to produce complementary «molecular imp-
rints». These «catalytic imprints» could be made from the stable chemical analogs of transition state
(TSA) of the enzyme reaction. This approach was successfully developed by Richard Lerner group.
The alternative way to create abzymes was proposed by French colleagues (Daniel Thomas and
Alain Friboulet, University of Compiegne) and the author. This allowed us to generate abzymes
with acetylcholinesterase and protease activities. We used also autoimmune mice models to create
epitop-specific abzymes.This may give rise to biocatalysts with new functions, previously unknown 
for common enzymes, which may be very profitable for fine organic synthesis. This method stimu-
lated our attempts to make antibody-like acceptors for phosphorus-based poisons. Recombinant an-
tibodies with such functions were obtained in this lab using chemical selection of «na¿ve» phage-
display library. The X-ray of this antibody was made and 3D structure was solved. Other advantage
of abzyme field is the opportunity to make «catalytic vaccines». Numerous attempts to combat HIV
infection using drug therapy as well as classical vaccination turned out to be ineffective. One of the
targets for the novel therapeutic approach may be the main surface antigen, viral envelope protein
gp120. The specific cleavage of this protein can lead to the dramatic changes in the immune res-
ponse toward virus and decrease binding of HIV to CD4 receptor.
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The research developed in the «Enzyme and Cell Engineering» laboratory is devoted to the study of
biocatalysis, mainly by creating new functions not existing in nature to explain actual life properties 
and to produce new tools for biotechnology and medicine. Catalytic antibodies (abzymes) were first
developed as tools in chemistry, or as laboratory curiosities. Our group has shown that the structural
and functional mimicry of the idiotypic network of immune system can be exploited to elicit cataly-
tic anti-idiotypic antibodies. Monoclonal antibodies with esterase, amidase and protease activity
were thus obtained. The data obtained indicate that the idiotypic network is capable, to a significant
extent, to replicate sophisticated catalytic apparatus of serine proteases, and further validates the use 
of mimicry of enzyme active centers by the immune system for induction of catalytic antibodies. On
the other hand, other groups have clearly demonstrated the presence of antigen-specific hydrolytic
antibodies in a number of inflammatory, autoimmune and neoplastic disorders, but also in the serum
of healthy donors; their pathogenic effects have been demonstrated occasionally. The origin of di-
sease-associated catalytic antibodies may have been «induced» by the antigen implicated in the di-
sease, may result from the loss of repressive control, or may be an expression of the idiotypic net-
work with exacerbated self-recognition in autoimmune diseases. To try to understand the mecha-
nisms resulting in the expression of catalytic antibodies in some diseases, the physiopathological ro- 
le of catalytic antibodies has been investigated in various diseases. Finally, the field of catalytic an-
tibodies has brought lessons to understand the molecular architecture necessary for regulating  cata-
lytic activity. On the one hand the selection of peptides from the diversity of libraries expressed on
the surface of bacteriophages allow the characterization of efficient peptides. On the other hand, the
preparation of molecularly imprinted polymers (MIP) is another way using molecular mimicry to
obtain synthetic compounds able to act as artificial antibodies, or as specific inhibitors of enzyme
activities.
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One of the major functions of the proteasome is to generate peptides that are further presented on the
MHC I molecules. This particular process is extremely important for immune system and specifi-
cally for cytotoxic lymphocytes to distinguish friend from foe. IFN-γ-inducible immunoproteasome
reveals different protein degradation pattern and is thought to be key player in antigen presentation
during inflammation. This investigation is devoted to the elucidation of Myelin Basic Protein
(MBP) degradation via proteasome pathway. This autoantigen is highly involved in neurodegenera-
tion and neuroinflamation processes and has intimate links with the development of multiple scle-
rosis (MS) and experimental autoimmune encephalomyelitis (EAE). Quantitative LC-ECI-MS
comparative analysis of MBP degradation by proteasomes from mice brain and set of MS-associated 
proteases displayed unique property of proteosome machinery during autoimmune demyelination to 
efficiently generate MBP immunodominant fragments – especially encephalitogenic peptide
ENPVVHFF. Consequent presentation of processed myelin antigens to autoreactive T-cells may in-
duce their activation and cytotoxicity thus enhancing inflammation and demyelination and even ser- 
ve as a trigger of the disease. To understand the nature of this process we analyzed the influence of
proteasome catalytic subunits composition on MBP degradation pattern. We showed that the level
of immunoproteasome is dramatically elevated in brain of EAE SJL mice in comparison with na¿ve
SJL and BALB/c mice. Resident neuronal cells, oligodendrocytes and astrocytes were shown to car- 
ry mainly immunoproteasome with catalytic subunit LMP2 while another one LMP7 was coloca-
lized with  infiltrating lymphocytes. Specific LMP2 inhibitor was shown to be efficient blockader of 
brain-derived immunoproteasome activity. This may be countered by giving immunoproteasome-
targeted inhibitors for therapy of ongoing autoimmune neurological diseases.
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Aim. Pediatric autoimmune diseases including juvenile idiopathic arthritis (JIA), type 1 diabetes,
bronchial asthma, form an important cause for physical handicap and disablement in early age. The-
se are multifactorial pathologies developing on hereditary basis as result of interaction between
environmental factors and the patient’s organism [1]. Despite numerous studies on molecular ge-
netics of autoimmune diseases prominent associations were not identified up till now. The odds ra-
tio (OR) values are usually low and change depending on populations. It seems that the identified
risk genes are responsible for a small part of the genetic contribution, but predisposition is deter-
mined by other, yet unrevealed loci [2, 3]. Creation of genetic markers strongly associated with hu-
man autoimmune diseases could form a basis for elaboration of a method for early diagnosis of auto- 
immune diseases. Chromosome 14q polymorphisms appear to be prospective markers of autoim-
mune diseases, as it encodes several proteasomal genes. Proteasomes are involved in pathogenesis
of autoimmune diseases. Methods. The polymorphisms were genotyped in a case/control study
composed of 170 JIA patients and 233 subjects without JIA. Conventional genotyping techniques
(fragment analysis, primer-specific PCR, restriction site polymorphism and sequencing) were ap-
plied. Results. Our findings have proven the initial hypothesis. Alleles of two microsatellites (short
reiterated sequences) localized in the region appeared to be associated with juvenile idiopathic
arthritis (JIA) with a low P values and high OR values. The (AC)5AT(AC)15 allele of the HSMS701
marker is strongly associated with the risk of JIA development (P = 4.9 ⋅ 10–5, OR = 15.43). The
(AC)5AT(AC)18 allele of the HSMS701 marker and HSMS702 (TG)10 allele also turned out to be
JIA risk factors (P = 1.09 ⋅ 10–3, OR = 3.16 un P = 2.00 ⋅ 10–3, OR = 7.39 correspondingly) [4]. Several 
single nucleotide polymorphisms, especially replacement of cytosine codon with adenine codon in
–110 position of the PSMA6 gene also can be considered to be a JIA risk factor [5]. Proteasomal
ATPase gene PSMC 6 (14q21.1) SNP c. 86–104 T > A appears to be associated with JIA oligo-
arthritis form (P < 0.05). These results indicate impact of alleles on the disease development risk.
Thus the existing preliminary data indicate strong association of this locus with JIA. Determination
of the locus allele polymorphisms could be used for prognosis of autoimmune disease development
during the first year of the life.
 
             1. Rumba-Rozenfelde I. et al. (2009) Risk factors of children diseases. In: State programme in medical science, Riga (In Latvian) 
                      2. Hinks A.  et al. Arthritis Rheum. 2009 Jan; 60 (1): 258–263. 
                      3. Smerdel A.  et al. Genes Immun. 2004 Jun; 5 (4): 310–312. 
                      4. Sjakste T. et al. (2010) DNA and Cell Biology (in press). 
                      5. Trapiòa I. et al. Proceedings of the Latvian Academy of Sciences Section B, 2009, V. 63, No. 4/5, P. 214–221.
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Immunoglobulins were shown to serve as an excellent template to generate de novo catalytic active
centers. Both combinatorial and rational design approaches were used to improve their catalytic
efficiency for numerous reactions. Organophosphorous poisons (OP, nerve gases) may be regarded
as one of the intriguing targets to develop antibody-based capturing machinery. Previously we
obtained rationally designed antiidiotypic antibodies 9A8 against acetylcholinesterase which was
shown to have pronounced specificity of its active center toward OP analogs. Its 3D model showed
Ser-His dyad, responsible for catalysis. Alternatively using combinatorial selection of human phage 
display library by non-toxic phosphorus compounds we selected A17 ScFv antibody able to capture
OP analogs. This antibody was expressed as full length antibody in CHO cells, Fab-fragment of it
was crystallized and two 3D structures of non-modified and modified by phosphonate residues were
solved with resolution 1.5 and 1.36 C respectively. The 3D structures of 9A8 and both A17 antibo-
dies were compared and mechanism of OP capturing was described. We failed to show any similari-
ties on the level of primary and 3D structures with corresponding enzymes. The microcalorimetric
studies allowed us to make quantitative conclusions concerning active sites of both antibodies.
Rationally designed 9A8 has more dance active site, alternatively combinatorial selected A17 poses
«primitive» rigid active center. 9A8 antibodies was interact with fluorescent analog of soman. A17
antibody hydrolyze paraoxon with low rate constant. These antibodies displayed certain specificity
toward DNA. Rationally designed 9A8 was characterized as specific dsDNA binder and A17 was
shown to catalyze dsDNA cleaving reaction. Thus both Abs has pronounced promiscuity of their
catalytic centers.
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Burkitt’s lymphoma (BL) is a relatively rare non-Hodgkin lymphoma. Most BLs carry a translo-
cation of the c-myc oncogene from chromosome 8 to either the immunoglobulin (Ig) heavy-chain
region on chromosome 14 [t(8;14)] or one of the light-chain loci on chromosome 2 (kappa light
chain) [t(8;2)] or chromosome 22 (lambda light chain) [t(8;22)]. The major translocation juxtaposes
Ig heavy chain gene (/IGH/, 14q32) sequences with the c-myc locus, leading to an overexpression of 
a number of genes, including the c-myc gene. In many cases, particularly in African children and
AIDS patients, BLs are associated with Epstein-Barr virus (EBV). Several hypotheses have been put 
forward to explain this association, but the issue is not completely resolved. We have studied the
intranuclear localization of c-myc and IgH loci in normal B lymphocytes and found that they are
co-localized in the nuclear space only in 3 % of studied nuclei, with the IgH locus being localized in
the center of the nucleus, and c-myc in the nuclear periphery. C-myc moves to the center of the
nucleus upon EBV infection and IgH-c-myc co-localization is increased fivefold, to 15 %. This
co-localization is a necessary pre-requisite of translocation that leads to BL. We are currently stu-
dying the role of specific EBV proteins in induction of this rearrangement.
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Aim. Mammalian proteins RUNX1, RUNX2 and RUNX3 belong to the family of transcription fac-
tors CBF. As these factors appeared early in the evolution they participate in the regulation of the pi- 
votal processes in the organism. So, the human RUNX1 protein coordinates hematopoiesis, nerve
system development and angiogenesis. In the past 10 years the structure of the protein and it’s do-
wnstream targets as well as the intron-exon structure of the gene RUNX1 were studied thoroughly.
The point mutations, deletions and duplications of the locus, containing the RUNX1 gene, were elu-
cidated shortly after the structure became clear. But the most attention was drawn to the chromoso-
mal translocations of RUNX1 gene as they are the cause of acute myeloid leukemia. Therefore, the
RUNX1 gene itself has been a good model for studying the mechanisms of chromosomal trans-
locations. However, though so much is known about the RUNX1 and it`s product it remains quite
unclear how the tissue-specific regulation of the gene is established. There are two promoters that
guide the expression of RUNX1, the distal one placed before the first exon and the proximal one
inside the second intron of the gene. But it was proved that the promoters do not have any tissue spe-
cificity. Thus, there should be some extra regulatory elements that control the promoter activity. So
the aim of the present study was to identify such elements. Methods. Genetic constructs on the basis
of pGL3 vector containing promoters and potential regulatory elements from RUNX1 gene were
prepared. Lymphoid and epithelial cells were transfected with these vectors. After 24 hours incuba-
tion the luciferase luminescence was measured in the cell extracts using standard Double Luciferase
assay kit. The in vitro interaction of tissue-specific transcription factors with these regulatory
elements was checked with the help of electrophoretic mobility shift assay (EMSA). The in vivo in-
teractions of the promoters with their regulatory elements was established through 3C (Chromoso-
me Conformation Capture) analysis. Results. In the transient transfection experiments we managed
to identify two potential enchancers regulating the corresponding promoters. In electrophoretic mo-
bility shift experiment we observed the formation of DNA-protein complexes with the enchancer
elements only in the extracts prepared from lymphoid cells. Using 3C assay we managed to charac-
terize the spatial organization of the RUNX1 gene and to verify in vivo promoter-enchancer inter-
actions. Conclusions. In this work we identified two novel cis-regulatory elements that guide tis-
sue-specific expression of human RUNX1 gene. Considering the genomic positions of these newly
characterized elements our study might be helpful for  further investigation of molecular mecha-
nisms leading to leukemogenic chromosomal translocations. 
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The role that the IGF system plays in tumor progression makes it a target for cancer therapy. At the
same time, oncogenic redundancy is a significant obstacle to successful treatment. Although  IGF-I
was proposed as one of the targets for tumor therapy, enhanced IGF-I expression was not found in
astrocytomas. This may explain why the anti-IGF-I treatment does not give positive results, sup-
posing that the development of glial tumors is activated by some other way. IGF-I participation in
cellular signaling pathways of glioblastoma may be substituted by highly expressed IGF-II as well
as high expression of IGF-IIR. Overexpressed IGFBPS activates IGF even without increasing li-
gand expression that also leads to anti-apoptotic consequences. Other proteins may also stimulate
both main signaling pathways in glial tumors. In fact, CHI3L1 works in a synergistic fashion with
IGF-I: both initiate MAPK and PI3K signaling cascades (Recklies et al., 2002) and activate mitoge-
nesis. As we have shown recently, CHI3L1 with the pronounced increased expression in tumor sti-
mulates proliferation and possesses the oncogenic properties. CHI3L2 also has a significantly in-
creased expression in glioblastoma and activates ERK1/2 but decreases mitogenesis and inhibits
cell proliferation. While stimulation of ERK1/2 phosphorylation by CHI3L1 gave short activation
of ERK1/2 leading to a proliferative signal, the treatment with CHI3L2 gave the sustained activa-
tion. The arguments put forward in the previous and present works propose that when cells make
decision  about proliferation versus differentiation, they do it by differences in the duration of ERK
activation and by translocation of ERK1/2 to the cell nucleus. However, a serious limitation of this
model is that it was based wholly on experiments with PC12 cells, which may represent an abnormal
system. Here, other cell type, namely HEK293 cells, had also sustained ERK1/2 activation after
treatment by CHI3L2 that makes differences in the duration of ERK activation as a common signa-
ling effect leading to proliferation or differentiation. What is a difference between CHI3L1 and
CHI3L2? They are quite high homologous, have the same NH2-residues; their 3D-structures are al-
so very close. The main difference between them is that YKL-40 is N-glycosylated at Asn60. IGF-
system targeting for anticancer therapy is rapidly becoming a clinical reality, so an understanding of 
the complexity of this system is very timely.
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Aim.  In addition to dopaminergic (DA-ergic) neurons expressing all the enzymes of DA synthesis,
tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AACD), the neurons expres-
sing one of the enzymes, TH or AADC, were discovered.  These neurons are distributed all through
the brain though they appear to be particularly numerous in the hypothalamic tubero-infundibular
system (TIS). This study was aimed to test our hypothesis that the neurons expressing individual
complementary enzymes of DA synthesis produce this neurotransmitter in cooperation. It means
that L-tyrosine is transformed to L-DOPA in TH-containing neurons that is followed by L-DOPA
transfer to AADC-containing neurons for its conversion to DA. Methods. DA synthesis was estima- 
ted under static and perifusion incubation of tissue slices of TIS and substantia nigra (control) of
adult rats in the presence or in the absence of L-leucine or L-methionine. These amino acids were
used as competitive inhibitors of L-DOPA uptake to AADC-containing neurons. The total amount
of DA in tissue extracts and in the incubation medium measured with the high performance liquid
chromatography with electrochemical detection after 1.5 hour incubation was considered as an
index of DA synthesis. Moreover, we have used the double-immunolabeling of AADC and TH on
vibratome sections of TIS with peroxidase and gold particles intensified with silver, respectively.
This has been done for evaluation of topographic relations between the monoenzymatic neurons.
Results. An incubation of the TIS slices in the presence of either L-leucine or L-methionine resulted 
in the decrease of the DA contents both in slices and the incubation medium. The same procedures
with the slices of the substantia nigra did not modify the DA contents in the tissue and incubation
medium. The above data show that L-leucine and L-methionine inhibit DA synthesis in the TIS en-
riched in monoenzymatic neurons whereas they do not influence on this synthesis in the substantia
nigra consisting of bienzymatic DA-ergic neurons. These data are considered as the direct proof of
DA synthesis by monoenzymatic non-dopaminergic neurons. According to our double-immunola-
beling study, the monoenzymatic axons, TH- and AADC-immunopositive axons, in the TIS are in
apposition with each other as well as with bienzymatic axons. Close topographic relations between
the monoenzymatic axons suggest their functional interaction serving to transfer L-DOPA from TH- 
containing axons to AADC-containing axons. Conclusions. The TIS monoenzymatic non-dopami-
nergic neurons expressing complementary enzymes of DA synthesis produce this neurotransmitter
in cooperation that is facilitated by close topographic relations in-between.
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Aim. Two early symptoms in Parkinson’s disease (PD) are alteration in olfaction and depression. Intri-
guingly, these symptoms may target neuronal changes in the two restricted regions showing adult
neurogenesis, the subventricular zone (SVZ) – rostral migratory stream (RMS)-olfactory bulb (OB)
continuum and the dentate gyrus (DG) of the hippocampus. In both regions, production of new inter-
neurons is involved in memorization processes, as odor recognition in OB and hippocampal dependent
spatial memory in DG. Furthermore, adult neurogenesis in DG has also been associated to stress and
antidepressant effects in animal models of depression. Finally, loss of dopamine, which is the patholo-
gical hallmark of PD, also affects adult neurogenesis in rodent and human. The aim of the present study
was to examine the effect of a recent efficient treatment of PD: the high frequency stimulation of sub-
thalamic nucleus (STN HFS), on adult neurogenesis in rats with unilateral lesion of DA cells in the sub-
stantia nigra pars compacta. Method. Male wistar rats were divided in three experimental groups: sham
of lesion and STN electrode implantation (n = 7), lesioned rats stereotaxically injected with 6-hydroxy-
dopamine (6-OHDA; 12 µg/6 µl saline plus ascorbic acid 0.1 %) in the left substantia nigra and imp-
lanted with an electrode in STN (n = 8), and 6-OHDA lesioned rats with STN electrode implantation and
stimulation (n = 8). Electrode implantation was performed 2 weeks after lesion; stimulation started 1
week later and lasted for 8 days. STN HFS was applied continuously on freely moving rats with the
following parameters: frequency 130 Hz, pulse width 80 µs, intensity 80 µA over the stimulated period.
To study new cell survival, bromodeoxyuridine (BrdU), a mitotic marker that remains in the DNA even
after cell division, was injected the first day of stimulation (5 × 75 mg/kg i. p. every 2 hours). Rats were
perfused at the end of the stimulation period. Cell proliferation was studied using immunostaining for
Ki67. Confocal microscope analyses allowed phenotype determination using double immunostaining
for BrdU and DCX (a marker of neuroblasts). To determine the extent of DA depletion, tyrosine hydro-
xylase immunostaining (optical density) was quantified in the striatum and accumbens. Results. Unila-
teral DA depletion was almost complete in the striatum (3 % of sham) and partial in the nucleus
accumbens (35 % of sham); STN HFS increases TH level in both regions (14 % in striatum and 73 % in
the accumbens). In the SVZ, cell proliferation was slightly (17 %) but significantly decreased in the
lesioned side, an effect correlated to TH level, while cell survival was decreased in both sides and not
correlated to TH level. STN HFS did not affect cell proliferation, but increased cell survival. Such a
stimulatory effect of STN HFS on cell survival was also observed in the RMS and OB. In the DG no
changes in cell proliferation were observed after lesion with or without STN HFS, while significant
decreases in cell survival were observed on both sides of lesioned animals, and reversed by STN HFS.
Lesion or stimulation did not affect the phenotype of newly formed cells. These results indicate a potent
restorative effect of STN HFS on adult neurogenesis in every regions examined that may have positive
consequences on OB and DG functions. 
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Introduction. Facioscapulohumeral muscular dystrophy (FSHD), a dominant hereditary disease
with a prevalence of 1 in 20,000 individuals, is caused by a partial deletion in the subtelomeric D4Z4 
repeat array on chromosome 4q. Results. Here we show that a strong transcriptional enhancer
within the D4Z4 repeat unit interacts with the Kruppel-like factor KLF15 and that the expression
level of KLF15 regulates the activity of the D4Z4 enhancer which, in turns, induces expression of
DUX4c in a KLF15-dependent manner. During muscle differentiation, increased expression of
KLF15 activates the D4Z4 enhancer leading to activation of the promoter of the DUX4c gene.
Furthermore, we show that KLF15 is expressed at higher levels in muscle biopsies from FSHD
patients compared to controls. Higher expression of KLF15 in muscles of FHSD patients could in-
duce untimely overexpression of DUX4c with deleterious effects on muscle cell differentiation.
Conclusions. We suggest that the KLF15-controlled D4Z4 enhancer may play a role in normal and
pathological development of muscular cells. 
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Poly(ADP-ribose) polymerase 1 is a key regulator of
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Aim. Poly(ADP-ribose) polymerase 1 (PARP1), functioning as DNA nick-sensor, interacts with base
excision repair (BER) DNA intermediates containing single-strand breaks. Bound to DNA breaks,
PARP1 catalyzes synthesis of poly(ADP-ribose) covalently attached to some nuclear proteins and itself.
Autopoly(ADP-ribosyl)ation of PARP1 facilitates its dissociation from DNA breaks and is considered
as a factor regulating DNA repair. The aim is to study the role of PARP1 and its autopoly(ADP-
ribosyl)ation in regulation of damage processing by the BER enzymes. Methods. Affinity modification,
MALDI-TOF-MS, enzyme functional tests. Results. We identified PARP1 among the BER proteins
cross-linked to the photoreactive branch-point BER DNA intermediate. Apurinic/apyrimidinic
endonuclease 1 (APE1), DNA polymerase β (Pol β), flap endonuclease 1 (FEN1) were found to crosslink 
to the same BER intermediate. By functional assays in reconstituted systems, as well as in cell extracts,
we demonstrated that PARP1 and its poly(ADP-ribosyl)ation was involved in regulation of activity of
the base excision repair enzymes – APE1 (3'-5' exonuclease activity), Pol β, FEN1. PARP1 was shown to 
more efficiently influence DNA synthesis in long patch BER and its poly(ADP-ribosyl)ation pathways.
PARP1’s ability to interact with intact AP sites and AP sites processed by APE1 via covalent via Schiff
base intermediate was demonstrated in cell extracts and with pure PARP1 protein. The identity of
PARP1 as the target for cross-linking to AP sites in cell extracts was proved by peptide mapping on the
data of MALDI-TOF-MS. PARP1 is unable to cleave AP sites, but instead forms with AP sites a stable
intermediate. PARP1 is unable to be autopoly(ADP-ribosyl)ated upon binding with AP sites until pro-
cessing of AP site by APE1. Conclusions. Thus, in addition to well-known role of PARP1 as nick-
sensor, we demonstrated potential role of this protein in regulation of earlier stage of the BER process
preceding incision of sugarphosphate backbone of DNA. Interaction of PARP1 with AP sites along with
the previously detected interaction with DNA breaks demonstrates that PARP1 is a key sensor of lesions
appeared in BER. PARP1 can regulate initial stage of BER persisting on AP site until APE1 could come
and initiate AP site cleavage. The PARP1 activation and resultant automodification appears to facilitate
the BER factor recruitment to stimulate the repair process. In the absence or deficiency of APE1, PARP1 
can provide temporal protection of AP sites. PARP1 is able to interact also with AP sites cleaved by
APE1. However, in the absence of Pol β, when the removal of 5' deoxyribose is failed, interaction of
PARP1 with this intermediate stimulates synthesis of poly(ADP-ribose) polymer, which is known as a
death signal. Acknowledgements. This work was supported by RFBR, projects N 10-04-01083,
09-04-93106, 08-04-00704 Program of RAS «Molecular and Cellular Biology» and State contract
N 02.740.11.0079. 
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Thyroid-transcription factor-1: a new gene 
targeted by the Wnt/β-catenin pathway
M. Gilbert-Sirieix, L. Massade
UMR CNRS 8203 Vectorologie et Therapeutiques anticancereuses Institut Gustave Roussy
Villejuif, France
liliane.massade@igr.fr
Introduction. The Wnt signaling pathway has recently emerged as a critical pathway in carcinoge-
nesis. Furthermore, many β-catenin targets have been shown to play important roles in cancer in-
cluding c-myc, cyclin D1, matrix metalloproteases, CD44 or homeodomain-containing genes. In the 
Papillary Thyroid Carcinoma (PTC), the RET/PTC rearrangement is known to induce the disease
but the mechanisms involved in the promotion of the pathology are still unknown. On the other
hand, thyroid-transcription factors like thyroid transcription factor-1 (TTF-1), thyroid transcription
factor-2 (TTF-2) or paired box gene 8 (Pax8) seemed also to be involved in thyroid cancer genesis
and progression. Aim. The purpose was to investigate whether Wnt/β-catenin pathway would regu-
late TTF-1 expression and to assess the role of molecular canonical Wnt pathway components in the
TTF-1 regulation. Results. We first demonstrated the activation of the pathway in a thyroid car-
cinoma cell line which express the RET/PTC1 oncogene (TPC-1): we showed the presence of the
different components of the pathway by immunocytochemistry and PCR and use RNA interference
to target some of them. We observed a down-regulation of the TTF-1 gene and protein expression.
We next proceeded to the reverse study where the Wnt pathway is over activated in the cell line by
using LiCl and SB216763 and we showed a TTF-1 gene and protein induction confirmed by the
presence of an active TCF/LEF response element in the TTF-1 promoter detected with different
promoter deletions and ChIP analysis. Conclusions. This study underlines the regulation of TTF-1
by the Wnt/β-catenin pathway at transcriptional and transductional levels and provides evidence
that TTF-1 would be a new target gene of the Wnt/β-catenin pathway and could be investigated in the 
treatment of aggressive or persistent PTC. 
Latent membrane protein 2A (LMP2A) 
of Epstein-Barr virus interacts with endocytic adaptors:
intersectin 1 and amphiphysin 1
O. Dergai, M. Dergai, I. Skrypkina, L. Matskova1, L. Tsyba, 
G. Winberg1, A. Rynditch 
Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine
150, Academika Zabolotnogo Str., Kyiv, Ukraine, 03680
1Karolinska Institute
Stockholm, Sweden
o.dergai@gmail.com
Aim. Epstein-Barr virus is a member of the herpes virus family and one of the most common human
viruses. EBV is associated with a number of human malignancies, such as Burkitt’s lymphoma,
Hodgkin’s lymphoma and the epithelial cell malignancy nasopharyngeal carcinoma (NPC). Only
restricted set of viral genes is expressed within latent phase: LMP1, LMP2A, LMP2B, EBNAs and
EBERs. Latent membrane proteins are key player of infected cells transformation. But little is
known about mechanism governing internalization and trafficking through cells compartment The
aim of current work is to identify protein-protein interaction that allows latent membrane proteins to 
get access to the host endocytic machinery. Methods. Using molecular cloning techniques and
site-directed mutagenesis set of plasmids harboring CDS and its variants of LMP2A, LMP2B,
LMP1 and endocytic proteins have been obtained. Standard GST-pull down and immunoprecipi-
tation assays were used to assess interactions, conditions of complexes formation between host
targets and viral proteins. Immunofluorescence analysis with set primary monoclonal antibodies
followed by appropriated Texas-Red or Alexa405-conjugated antibodies. Results and conclusions. 
Here we report about interaction between viral protein LMP2A and endocytic adaptor intersectin 1.
Our immunoprecipitation data evidence about complex formation between LMP2A and ITSN1 in
vivo in HEK 293, MCF-7 cells and in B-lymphocyte cell line CBMI. SH3 domains of ITSN1 are
sufficient to precipitate LMP2A in vitro, thus it was supposed that ITSN1 binds -PXXP- motives of
LMP2A. Moreover, another endocytic adaptor – amphiphysin 1 has been found to bind -PXXP- of
LMP2A through its SH3 domain. Mutational analysis of LMP2A sequence indicates at least two
binding sites for ITSN1 and 3 for Amphiphysin. According to our data intersectin1 interacts with
both isoforms: LMP2A and 2B, while amphiphysin binds only LMP2A. Amphiphysin 1 associates
with two sites at the N-terminus of LMP2A which were known to mediate interaction of this viral
protein with ubiquitin-ligases. Thus, it is tempting to speculate that amphiphysin 1 compete with
mentioned ubiquitin-ligases inhibiting down regulation of LMP2A associated proteins like Syk and
Lyn. Analysis of subcellular distribution revealed co-localization of LMP2A and ITSN1 in clathrin- 
coated pits. Summarizing these data we can propose a model of clathrin-mediated internalization of
LMP2A which could be ITSN1-dependent.
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Responses of base excision repair proteins 
to oxidative stress
A. Bravard, A. Campalans, R. Amouroux, J. Hall1, B. Epe2, J. P. Radicella 
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Orsay, France
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Oxidative stress is the consequence of reactive oxygen species (ROS) accumulation that disrupts the
intracellular redox balance. All cellular macromolecules are potential targets for ROS, among them
nucleic acids. Because of its weak oxidative potential, the guanine base is the most susceptible to be
damaged by ROS. The 8-oxoguanine (8-oxoG), resulting from guanine oxidation, is highly mutagenic
and can lead to G:C to T:A transversions after two replication cycles. Mammalian cells possess a
specific DNA glycosylase, OGG1, which recognizes and excises specifically this oxidized base; these
first steps initiate the base excision repair (BER) pathway. Here we will present two different aspects of
the response to oxidative stress of the proteins involved in the initial steps of BER. Recent work from our 
laboratory concluded that after a strong oxidative stress OGG1 could by inactivated by thiol oxidation.
Here we show that the replacement of serine 326 for a cysteine, a polymorphic variant associated with
cancer predisposition, leads to a lower and more vulnerable cellular 8-oxoG repair capacity. Lympho-
cyte cell lines homozygote for either Cys or Ser alleles were analyzed for their in vitro and in vivo repair
capacities, showing that cells carrying the Cys variant systematically displayed a reduced in vivo capa-
city of 8-oxoG removal from their genome and increased genetic instability. Consistently, extracts from
these cell lines had 50% of the DNA glycosylase activity found in cells carrying the Ser allele.
Surprisingly, the activity of the Cys extracts could be taken to the levels of those from the Ser variant by
addition of a reducing agent, while the Ser one was not affected. Conversely, the Cys variant was more
readily inactivated by exogenous oxidative stress. Biochemical assays confirm that the oxidation of the
form carrying the extra cysteine residue is at the basis of the impaired DNA repair capacity of OGG1
S326C and therefore could explain its association with cancer predisposition. Secondly, we will show
some recent cellular and biochemical results describing the relocalization to specific regions of the
nucleus of OGG1, APE1 and XRCC1, proteins involved in the initial steps of the 8-oxoG BER. After
exposure to an oxidative stress generating large amounts of 8-oxoG in DNA, OGG1, together with the
other two BER proteins is recruited to chromatin. By both, biochemical and microscopy approaches we
show that the DNA glycosylase specifically relocates to the euchromatin fraction. Compaction of
chromatin using  hypertonic treatment of the cells strongly inhibits in vivo repair. Furthermore, kinetic
experiments using OGG1 mutants indicate that completion of repair is required for release of the DNA
glycosylase. Taken together our results suggest a mechanism by which, in response to oxidative stress,
the cell triggers a preferential repair of 8-oxoG in active chromatin regions.
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Poly(ADP-ribose) polymerases in the DNA 
damage response: new incomers
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Poly(ADP-ribosyl)ation is a post-translational modification of proteins mediated by Poly(ADP-
ribose) polymerases (PARPs). It occurrs in various cellular processes such as DNA repair, repli-
cation, transcription, telomere homeostasis, mitotic segregation or cell death. PARP-1 is a mole-
cular sensor of DNA breaks that signals their presence by synthesizing poly(ADP-ribose) (PAR),
which modifies chromatin architecture and recruits DNA repair factors at the damaged site. Whe-
reas activation of PARP-1 by mild genotoxic stimuli facilitates DNA repair and cell survival, in-
tense PAR production upon massive DNA attack triggers cell death. PARP-1 inhibitors have entered
clinical trials to potentialize the cytotoxicity of clastogens in radio- and chimiotherapy, but also to
sensitize cells with genetic defects in double-strand break repair such as BRCA-deficient cells. Our
laboratory has established in silico the sequence of novel PARPs, bringing to 17 the number of PARP 
family members. The diversity of functional domains associated to the PARP domain, the va- rious
subcellular localizations and the novel functions discovered considerably extended the field of
poly(ADP-ribosyl)ation reactions. We have cloned and characterized PARP-2, demonstrating that it
is also a DNA damage dependent PARP, required for efficient DNA strand breaks repair. Cellular
and animal models deficient in PARP-1 or PARP-2 developed in the laboratory revealed redundant
and complementary functions of these two proteins in the surveillance and maintenance of genome
integrity. These models pointed also to specific functions in differentiation processes. Biochemical
analyses are now being conducted to determine the mechanism of action of PARP-2 in the DNA da-
mage response. Results on the identification of PARP-2 DNA targets and activators will be presen-
ted. PARP-9 is a protein overexpressed in some high-risk B lymphomas. It contains two macro do-
mains, the non-histone domain present in the histone variant macroH2A involved in transcriptional
silencing and chromosome X inactivation. PARP-9 macro domains were reported to efficiently bind
PAR, questioning whether PARP-9 could be recruited at sites of intense poly(ADP-ribose) syn-
thesis such as DNA strand breaks. To gain insights into the function of PARP-9, we have generated a
human cell line that efficiently down regulates the expression of PARP-9. The results will be pre-
sented on the consequences of PARP-9 deficiency on the cell response to DNA damage.
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The siRNA targeted to mdr1b and mdr1a mRNAs in vivo
sensitizes murine lymphosarcoma to chemotherapy
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Background. A substantial progress in the study of cancer development was achieved during last
decades. However, mortality from these diseases still remains high despite the appearance of new
highly efficient therapeutics and new polychemotherapy programs. One of the main obstacles for
successful polychemotherapy of cancer diseases is the development of multiple drug resistance (MDR)
phenotype, the resistance to a wide range of chemotherapeutic agents, acquired by cancer cells.
Currently, RNA in- terference represents a perspective strategy to overcome MDR via silencing the
genes involved in de- velopment of this deleterious phenotype (genes of ABC transporters,
antiapoptotic genes, etc.). Aim. In this study, we used the siRNAs targeted to mdr1, mdr1a, and bcl-2
mRNAs to reverse the MDR of tu- mors and increase tumor sensitivity to chemotherapeutics. Methods.
In our previous work (Mironova et al., Ann. NY Acad. Sci. 2006, 1091: 490–500) RLS40 cell line,
exhibiting MDR. The MDR of RLS40 cells was provided by a high expression of mdr1b and mdr1a
genes and a moderate expression of bcl-2 and appeared as a 20-fold decrease in the cell sensitivity to a
wide range of cytostatics (cyclophospha- mide, cysplatin, vinblastine, and rubomycin). The obtained
RLS40 cell line generates tumors in mice and mimics the tumor status observed in patients after several
chemotherapy courses (Zenkov et al., Nucleosides, Nucleotides, Nucleic Acids 2004, 23: 843–847).
Thus, we had at our disposal two lymphosarcoma models displaying MDR: the MDR of RLS40 is
mdr1b/1a-associated and the MDR of RLS tumor is predominantly bcl-2-associated. The antitumor
therapy consisting in ex vivo or in vivo application of siRNA targeted to mdr1a, mdr1b and bcl-2
mRNAs followed by cyclophosphamide administration was applied to the mice bearing RLS40 or RLS
lymphosarcoma. The dynamics of tumor growth as well as levels of genes expression and sensitivity of
siRNAs-treated  tumor cells to vinblastine was examined. Results. Our data show that mdr1b/1a and
bcl-2 siRNAs caused five- and two-fold de- crease in the corresponding mRNA levels, respectively, and 
mdr1b/1a siRNA exerted an increase in cell sensitivity to cytostatics. The application of siRNA
followed by cyclophosphamide administration was studied ex vivo and in vivo using RLS40 and the
related RLS lymphosarcomas developed in mice. Single application of mdr1b/1a siRNA and
cyclophosphamide resulted in a decrease in the MDR and a three- fold decrease in the tumor size as
compared with the control animals treated only with cyclophos- phamide, while bcl-2 siRNA was
ineffective in vivo. Conclusions. In perspective, mdr1b/1a siRNA may become a well-reasoned
adjuvant tool in the therapy of MDR malignancies.
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Cel lu lar lo cal iza tion of YB-1 un der vary ing 
anti-can cer drug ex po sure and stress
V. Joshi, L. Hamon, L. P. Ovchinnikov1, D. Pastre, P. A. Curmi
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EA3637, Evry, France, 91025
1Institute of Protein Research, Russian Academy of Sciences
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The ubiquitous Y box-binding protein (YB-1) binds to nucleic acids and participates in the regula-
tion of gene expression and translation. In addition, this protein may protect cells from the toxic ef-
fects of agents that lead to DNA cross-linking, suggesting a role in multidrug resistance. We gene-
rate novel YB-1 antibodies against synthetic peptides corresponding to a wild type of P-YB-1 to
probe it intracellular localization in control cells or after their exposure to different agents such as
cisplatin, mitomycin C, vinblastine, doxorubicin. The results show  variation of the YB-1 protein lo- 
calization under different conditions as probed by western blotting and indirect immunofluorescen-
ce microscopy.
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YB-1–PABP interplay in specific regulation 
of YB-1 mRNA translation
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Aim. The Y-box binding protein 1 (YB-1) is a member of the protein family with the cold shock
domain. It is involved in virtually all DNA- and mRNA-dependent events. The amount of YB-1 in
the cell strongly influences the transcriptome and proteome profiles of the cell, affects its
phenotype, prevents or promotes cell oncotransformation, and contributes to tumor aggressiveness.
Therefore, knowledge of the regulatory mechanisms of YB-1 synthesis may be useful for
development of novel approaches to cancer therapy. Previously, we found that the YB-1 mRNA
contains a regulatory element in its 3' untranslated region. This element specifically binds two major 
mRNP proteins, YB-1 and poly(A) binding protein (PABP). Their binding sites on YB-1 mRNA
overlap, and the two proteins compete for binding to the regulatory element. In doing so, YB-1
selectively inhibits (autoregulates) YB-1 mRNA translation, while PABP, in contrast, stimulates it
in rabbit reticulocyte lysates. In studying the mechanism of YB-1-PABP interplay in regulation of
YB-1 mRNA translation, a question arises as to whether these proteins act independently or the role
of one of them is reduced solely to displacement of the other from the regulatory element. The
specific task of our study was to answer this question. Methods. We obtained YB-1 mRNA forms
without the regulatory element or with a mutated element lacking specific affinity for either YB-1 or 
PABP. The effect of YB-1 and PABP on translation of these mRNAs was studied in the rabbit
reticulocyte cell-free translation system. Results. The deletion of the entire regulatory element from 
YB-1 mRNA results in elimination of both the negative effect of YB-1 and positive effect of PABP
on YB-1 mRNA translation. The mutation in the YB-1 binding site strongly decreases the inhibitory
effect of YB-1 and leaves the stimulating effect of PABP almost unchanged. With partially deleted
PABP binding site, YB-1 mRNA translation keeps being inhibited by YB-1, and PABP becomes
incapable of preventing this inhibition. Nevertheless, PABP preserves its ability to activate
translation of this mRNA form in the cell-free system. Conclusions. Thus, translation of YB-1
mRNA is affected directly and independently by the both proteins: negatively by YB-1 and
positively by PABP. This results from their specific binding to the regulatory element of this
mRNA. The opposite effects of these proteins on YB-1 mRNA translation can be enhanced through
their competition for binding to the regulatory element. Besides, PABP appears to be able to
stimulate translation of YB-1 mRNA even without specific affinity for the regulatory element. This
ability remains to be explained.
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Chitinase 3-like 2 gene as a potential marker 
of human glial tumors 
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Identification and characterization of differentially expressed genes in astrocytic gliomas, most
common glial tumors, can be expected to provide relevant and important insights into the molecular
determinants of tumor initiation, progression and diagnostics. Serial Analysis of Gene Expression
found CHI3L1 (YKL-40) and CHI3L2 (YKL-39) genes among the most abundant transcripts in
glioblastoma. Overexpression of CHI3L1 at the mRNA and protein levels in glioblastoma was
shown in our previous study CHI3L1 and CHI3L2 belong to the glycohydrolase family 18. Kawa-
mura et al. (1999) showed that a family of growth factors for imaginal disc cells of the fruit fly be-
longs to the chitinase-3 like protein family. Recklies et al. (2002) found that CHI3L1 stimulated
DNA synthesis and proliferation in a synergistic fashion with IGF-I by activation of both extra-
cellular signal-regulated kinase (ERK) – and protein kinase B (AKT)-mediated signaling cascades.
Taking into account the lack of similar data for CHI3L2, very closely related in size, amino acid and
nucleotide sequences (52 and 56 % homology) to CHI3L1, the present study was initiated to analyze 
the expression and functional role of CHI3L2 in glial tumors. Northern hybridization showed the
expression of CHI3L2 in the majority of glioblastomas. Anaplastic astrocytomas were possible to
divide on two groups: in one of them the CHI3L2 expression was completely undetectable, but in
another it was possible to detect quite high contents of CHI3L2 mRNA. CHI3L2 mRNA has not
been detected in eight samples of diffuse astrocytoma under investigation and was determined only
in 1 from 13 samples of normal brain. Western blot analysis of brain tumors revealed the 39 kDa
product in five of eleven analyzed glioblastoma samples and in five of thirteen anaplastic astro-
cytomas, but none from five samples of normal brain. CHI3L2 activates signal-regulated kinases
ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells.
Effect of CHI3L2 on PI3K/AKT signaling pathway is currently under investigation. Unexpectedly,
dose dependent decreases in total DNA content and [3H]thymidine incorporation were observed in
HEK293 cells treated with CHI3L2 at concentrations 50 and 100 ng/ml. CHI3L2 induced sustained
phosphorylation of ERK1/ERK2 in HEK293 cells in a very similar way to that was shown for PC12
cells treated with nerve growth factor (NGF). These data suggest that CHI3L2 may cause differen-
tiation phenotype, but not proliferation. Thus, increased expression of CHI3L2 at the mRNA and
protein levels in glioblastoma and its involvement in activation of MAPK signaling cascade may
suggest its potential role in carcinogenesis.
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Assembly of the tRNA3Lys packaging complex in HIV-1
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The human immunodeficiency virus,  HIV-1, infects cells of the immune system, and is responsible
for the acquired immunodeficiency syndrome (AIDS). This retrovirus contains a dimer of a single-
stranded RNA genome that must be converted into double-stranded DNA during viral replication.
The reverse transcriptase involved in this process is encoded by the viral genome. The tRNA3Lys
species from the host cell is used by the reverse transcriptase of HIV-1 as a primer for the synthesis
of the first, viral minus-strand DNA. During the budding process, all the viral components assemble
at the cell membrane in order to form new HIV-1 particles, which are then released outside of the
cell. During this step, the three tRNALys species of the host cell are specifically packaged into the vi-
ral particle1. One of the proteins responsible for the specific packaging of tRNALys has been iden-
tified as lysyl-tRNA synthetase (LysRS)2. In humans, there are two isoforms of LysRS, the cyto-
plasmic (cLysRS) and the mitochondrial (mLysRS) species. These two forms are encoded by the sa-
me gene by means of alternative splicing. The two LysRS species share a large part of their se-
quence, but it has been shown that the only source of LysRS detected in the virions is the mitochon-
drial form3, while the cytoplasmic form is exclusively found at the level of the Multi-Aminoacyl-
tRNA Synthetase Complex (MARS), a stable multiprotein assembly containing eight other amino-
acyl-tRNA synthetases. We used the yeast two-hybrid system to screen viral proteins that may form
a specific complex with LysRS. The Pol region of the polyprotein GagPol is able to interact with
LysRS. This interaction involves the p6* and IN domains of Pol. On the other hand, this interaction
involves the catalytic domain of LysRS, a domain shared by mLyRS and cLysRS. LysRS is also a
component of the cytosolic MARS complex. LysRS is associated within this complex via its inter-
action with the scaffold protein p38. We showed that this interaction is also mediated by the cata-
lytic domain of LysRS. The two LysRS species, cLysRS and mLysRS, are equally able to bind p38
in a two-hybrid assay, but only cLysRS is recovered within MARS. Thus, cLysRS and mLysRS
have the capacity to bind p38 or Pol in vitro, but only cLysRS is targeted to MARS, and mLysRS to
HIV-1 particles, in vivo. This implies that the two LysRS species follow distinct targeting pathways, 
to MARS or to the mitochondria, in vivo. 
              
             1. Jiang, M. et al. (1993) J. Virol. 67: 3246–3253.
               2. Cen, S. et al. (2001) J. Virol. 75: 5043–5048.
                     3. Kaminska, M. et al. (2007) J. Virol. 81: 68–73.
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Human cartilage glycoprotein gp-39 (YKL-40) 
has oncogenic properties 
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Aim. Gliomas are the most frequent malignant primary brain tumors. They are highly aggressive,
invasive, neurologically destructive and characterized by very high biological heterogeneity. It was
found earlier that CHI3L1 (human cartilage 39-kDa glycoprotein) gene is expressed at markedly
higher level in glioblastomas as compared to human normal brain. The previously published results
indicate that YKL-40, encoded by CHI3L1 gene, may be used as a potential molecular marker for
brain glial tumors. The aim of present study was to investigate oncogenic properties of YKL-40.
Methods. We established cell line stably expressed YKL-40. Presence of YKL-40 in cells was tes-
ted by Western-blot and immunocytochemistry. To determine whether YKL-40 possesses oncoge-
nic properties, we check ability of stably expressed YKL-40 cell line form colonies in soft agar. To
determine whether YKL-40 can influence tumor initiation and development in vivo, HEK293 cells
stably expressing YKL-40, and HEK293 cells transfected with the empty vector, were used for ste-
reotaxic intracerebral implantation to female Wistar rats. Tumor growth was monitored weekly for
up to 6 weeks. Results. Western-blot and immunocytochemistry analysis confirmed a presence of
YKL-40 in cells stably transfected by recombinant construction. The YKL-40-expressing clones
grew as colonies in soft agar. This property was not observed in the parental HEK293 cells or in
HEK293 cells transfected with the empty vector. After 21th day after implantation, tumors appeared
in three rats with implanted HEK293 cells which stably expressed YKL-40, two rats had smaller
tumor after one month. The volume of tumor was determined by approximating it with an ellipsoid.
The volume of the ellipsoid was equal to 443,9 mm3. No tumor growth was observed for at least six
weeks in five rats which were injected by empty vector-transfected HEK293 cells as a negative
control. Histochemical analysis of intracerebral tumor HEK293_YKL40 showed arrangement of
YKL-40 on the periphery of the tumor. Conclusions. Expression of YKL-40 in HEK293 cells was
sufficient to induce in vivo tumorigenicity. 
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Functional aspects of adaptor proteins 
of intersectin family
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Aim. The rich binding capability of the multidomain, adaptor and scaffolding proteins of intersectin 
(ITSN) family has linked them to multiple functions such as clathrin-mediated endocytosis,
mitogenic signaling and actin cytoskeleton rearrangements. Abnormalities of ITSN1 expression
were associated with the endocytic anomalies reported in Down syndrome brains, early stages of
Alzheimer’s disease as well as neurodegeneration in Huntingon’s disease. Overexpression of
INSN1 was sufficient to induce oncogenic transformation. Meantime, high level of ITSN2
expression in breast cancer was associated with good prognosis suggesting that minor differences in
the amino acid residues between these proteins could affect the binding properties. The other
sources of functional diversity can include alternative splicing and usage of alternative promoters.
Recently we identified 17 alternative splicing events for ITSN1 pre-mRNA. However, the function
of ITSN1 isoforms and their expression are not well defined. Moreover, little is known about
ITSN2. Methods. Immunoprecipitations, GST pull-down experiments, determination of sub-
cellular localization by direct and indirect immunofluorescence were used to study protein inter-
actions. To analyze the effect of ITSN2 domains overexpression on embryonic development,
microinjection of mRNA into the animal hemisphere of two-cell stage embryos were performed.
Results. We have compared interaction interfaces of ITSN1 and ITSN2 for their binding partners
and found four novel ITSN2 interacting proteins involved in endocytosis, RTK signaling and
rearrangements of actin cytoskeleton. Both intersectins interact with RLIP-associated Eps domain-
containing proteins, Reps1 and Reps2/POB1.The latter regulates the transport function of RLIP76,
an energy dependent transporter for glutathione-conjugates and chemotherapeutic agents, associa-
ted with multi-drug resistance. Phenotypic changes seen after manipulation of ITSN function in vivo
revealed the effect of ITSN2 on early embryonic development. Microinjections of mRNA encoding
different domains of ITSN2 into Xenopus embryos showed the strong hyperpigmentation, loss of
cell-cell contacts and gastrulation failure what was observed in case of overexpression of C-
terminal part of ITSN2 long isoforms (DH, PH and C2 domains). This effect was correlated with
alteration in the cortical actin cytoskeleton. Further experiments demonstrated that mechanism of
DH/PH domain function involved activation of small GTPase Cdc42. Dominant negative Cdc42
rescued loss of cell-cell contacts in case of DH/PH overexpression, increased embryos survival rate
and reduced severe hyperpigmentation effect. Moreover, wild type Cdc42 co-expressed with
DH/PH increased its deleterious effect supporting the idea of the role of DH domain GEF activity
towards Cdc42 in observed phenotype. Obtained results suggest a possible role of ITSN2 in the
coordinated changes of actin cytoskeleton during early embryonic development. Conclusions.
INSN1 and ITSN2 long isoforms are implicated in actin regulation and recruitment of endocytic
machinery. Defining the functional activities of intersectin alternative spliced isoforms is particu-
larly relevant given that the intersectins are involved either in neurodegenerative diseases or in
cancer.
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The Tran scrip tion Fac tor Cy cle (TFC) hy poth e sis 
and the genon-con cept
K. Scherrer
Institut Jacques Monod
CNRS, Paris, France
scherrer.klaus@ijm.univ-paris-diderot.fr
The Gene and Genon (GENe-operON) concept has emphasised the necessity to conceptually sepa-
rate genomic product information (the coding triplet sequence) from regulative information. Regu-
lative cis-programs are based on the sequential alignment of sites in DNA and RNA binding re-
gulative protein or RNA (within RNAi) factors. On an individual mRNA, added to and superposed
onto the coding sequence is the cis-program representing, thus, it’s Genon. The cis-genon picks up
an ensemble of factors from trans (it’s transgenon) by the sequential oligomotifs recognising protein 
or si/miRNA. The pre-mRNA carries the pre-genon program (controlling e. g. differential splicing)
and the DNA of a genomic domain its proto-genon controlling chromatin modulation as well as
transcription start and extent. The notion of such programs at DNA and (pre-)mRNA level became
most important recently, to interpret post-genomic data bearing on the unexpected extent of the
transcribed genome and the size of individual primary transcripts. Thus, all CRMs (cis-regulatory
modules) of promoter, enhancer and other types are transcribed. The sequence of CRMs way up-
stream, downstream and in intronic or intergenic positions represents thus a pre-genon; clear-cut
phenotypes relate to mutation of such CRMs without affecting the coding sequence. This may allow
interpreting old data in a new manner showing that factors that are assembled on DNA may be
carried away by the nascent transcript, to exert a function at RNA level. Certain factors binding
DNA with high affinity and site specificity are found predominantly on pre-mRNA. Some TFs and
promoter-binding factors also bind RNA. Hence, the possibility arises that TFs and other DNA-
binding factors might be transferred from chromatin to pre-mRNA or full domain transcripts
(FDTs); they may cycle back to the DNA in a balance controlled by relative affinity/specificity.
DNA might serve as «entry site» binding, and possibly organising into ensembles factors to be
carried away by the nascent RNA. FDTs have two functions: (i) control mRNA synthesis in cis and
(ii) bind from trans and store RNA-binding factors controlling gene expression. (1) In interphase
cells FDTs produce mRNA under the control of the pre-genon programs. (2) Producing some mRNA 
during mitosis and meiosis (e. g. histone mRNA) they might maintain the organisation of factors
fixed on pre-mRNA to be reinserted site-specific on «virgin» DNA. In mitosis, these factors might
be stored on not processed FDTs to be transferred back to the DNA in interphase. This might
perpetuate and control euchromatin open for transcription. In meiosis, when the genome is fully
transcribed and oocytes are full of high Mr RNA, the FDTs with their attached factors might be
disposed in sectors of the ooplasm. During cleavage stage they may end up in specific cells, feeding
specific factors to chromatin of individual cells. This process would correspond to a first stage of de- 
termination of later differentiation in space and time. The TFC concept also implies that mutations
of TF sites will affect not gene products per se, but interfere in the systems of regulative networks,
which control gene expression, leading to specific phenotypes.
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Ku antigen interacts with DNA containing abasic sites
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Aim. Prominent lesions in DNA are abasic (AP) sites arising spontaneously or as intermediates during
base excision repair. An AP site can form a Schiff base intermediate with primary amino groups of
proteins. This intermediate can be stabilized by NaBH4 treatment and, therefore, AP DNA can be used
as a tool in detecting proteins that interact with AP sites. This approach named borohydride trapping
(BHT). Methods. BHT and immunoprecipitation or MALDI-TOF-MS analysis were used for identifi-
cation of cross-linked protein to AP DNA. BHT and dot-ELISA were used to monitor the amount of Ku
antigen in different cell extracts. Results. In HeLa cell extract, a predominant product with an apparent
molecular mass of 95 kDa was observed. Analogous covalent adducts of proteins with AP DNA were
revealed in the extracts derived from human fibroblast, HL-60, K562, and several melanoma cell lines
unlike bovine testis nuclear extract. The cross-linked protein was identified as the p80 subunit (Ku80)
of Ku antigen (Ku) by immunoprecipitation and MALDI-TOF-MS analysis. Ku is an abundant DNA
end binding protein in human cells. Human Ku is composed of two tightly associated polypeptide
chains with molecular masses of 69.8 and 82.7 kDa (Ku70 and Ku80, respectively) and is the DNA
binding component of DNA-dependent protein kinase (DNA-PK). AP DNAs of different structure were 
used to study peculiarities of Ku interaction with DNA. Considering the extreme selectivity of AP
site-containing DNA probes, we decided to examine the use of this approach for measuring levels of Ku
in different cell extracts. The level of Ku in cancer cells is considered to be a relevant factor for the
prediction of tumour radiosensitivity and may play a role in treatment outcome. Ku expression was
shown to correlate with tumour and metastatic progression. Ku may act as either a tumor suppressor or
an oncoprotein, depending on its expression level. We found that quantitation by dot-ELISA and AP
site cross-linking were comparable. Cross-linking detected allows revealing truncated variants of Ku80
polypeptide (Ku80v) that is truncated at the C terminus, which are detected in some cells. The ability of
Ku80v complexes to interact with DNA-PK catalytic subunit (DNA-PKcs) is greatly reduced and
resulted in increased sensitivity to some DNA damage agents as a consequence of reduced DNA repair.
Conclusions. BHT unlike western blot or estimation of the Ku content, based on mRNA levels, reveals
Ku forms  that are active in DNA binding, including those, which have aberrations in Ku80, but retain
ability to heterodimerize with Ku70 and bind DNA. In addition, in  proposed assays no special
precautions for equal loading of samples on gels are required since the amount of Ku80 is estimated as
the ratio of AP DNA cross-linked to Ku80 to total AP DNA in the sample. Moreover, this approach can
be used to monitor the levels and forms of Ku80 separately in cytoplasmic and nuclear fractions of cells. 
As a routine test, this method is also less time and reagent consuming than blotting and EMSA. This
work was supported in part by RFBR (09-04-93106 and 10-04-01083), Program of RAS «Molecular
and Cellular Biology», Helmholtz-Russia joint research groups 2008 (HRJRG-102).
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Epigenetic changes of macrosatellite 3.3-kb repeats 
in human diseases 
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Aim. The members of 3.3-kb repeat family reside in the subtelomeric regions of chromosomes 4
and 10 as tandem repeats containing 11–100 monomers and on the short arms of all acrocentric
chromo- somes where repeats interspersed with 68 bp satellite DNA (van Geel et al., 2002; Lyle et
al., 1995).  Partial deletions of repeat array on chromosome 4 named D4Z4 are associated with
facioscapulohu- meral muscular dystrophy (FSHD), an autosomal dominant disorder. In many
normal somatic tis- sues, 3.3-kb repeats are mostly but not completely methylated and are
hypomethylated in glioblasto- mas, leukemia cell lines, and tissues of patients with FSHD (Cadeux
et al., 2006; Tsumagari et al., 2008; de Greef et al., 2010). Previously, we identified macrosatellite
3.3-kb repeats as hypermethy- lated in cervical cancer in genome-wide screening. Thus, hypo- and
hypermethylation of 3.3-kb re- peats are associated with several human diseases.  The aim of
present study is: 1) to confirm that hy- permethylation of 3.3-kb repeats is tumor-specific event; 2)
to investigate consequences of hypo- and hypermethylation of 3.3-kb repeats for disease cells.
Results.  For the first time, we have de- monstrated by bisulfite genomic sequencing that more than
50 % of cervical cancers display hyper- methylation of 3.3-kb repeats compared to normal cervical
tissues. Different regions within the 3.3- kb monomer exhibit inter-individual variation in the
methylation patterns in normal tissues and dif- ferent susceptibility to hypermethylation in tumors.
Mechanisms of these changes remain unknown. Recently, it has been shown that a nuclear matrix
attachment ragion (S/MAR) is located in the vi- cinity of the clusters of 3.3-kb repeats on 4 and 10
chromosomes. The S/MAR adjacent to the D4Z4 array was found to be prominent in normal human
myoblasts and non-muscular human cells, and was much weaker in muscle cells derived from
FSHD patients, suggesting that the D4Z4 repeat array and upstream genes are located in two
distinct chromatin loops in non-muscular cells and in normal human myoblasts vs a single loop in
FSHD myoblasts (Petrov et al., 2006). We have shown that methylation status of S/MAR is changed 
in cervical carcinoma cell lines compared to normal cervical tissues and correlates with changes of
3.3-kb repeats methylation status. Conclusions. It is known that some proteins that mediate
specific association of DNA with  nuclear matrix interact with the methylated DNA only (Horike et
al., 2005; Stratling and Yu, 1999). We propose that chan- ges in methylation of the subtelomeric
regions of chromosomes 4 and 10 are linked with changes in domain structure of chromatin in cells
of cancer and FHSD patients. This hypothesis is currently under study.
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